Nanoscale materials for probing the biological functions of the glycocalyx

Glycobiology

Volumn 26, Issue 8, 2016, Pages 797-803

  Huang, Mia L ^a   Godula, Kamil ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

glycocalyx; glycomaterials; nanomaterials; signal transduction

Indexed keywords

2,4 DINITROPHENOL; CD22 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; GALECTIN 1; MITOGEN ACTIVATED PROTEIN KINASE; NANOMATERIAL; BIOMIMETIC MATERIAL; MONOSACCHARIDE; POLYSACCHARIDE;

BINDING AFFINITY; CELL FUNCTION; CELL INTERACTION; EXTRACELLULAR MATRIX; GLYCOCALYX; HUMAN; MOLECULAR PROBE; NANOENGINEERING; NONHUMAN; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; CELL COMMUNICATION; CHEMISTRY; CYTOLOGY; EUKARYOTIC CELL; METABOLISM;

BIOMIMETIC MATERIALS; CELL COMMUNICATION; EUKARYOTIC CELLS; EXTRACELLULAR MATRIX; GLYCOCALYX; HUMANS; MONOSACCHARIDES; NANOSTRUCTURES; POLYSACCHARIDES; SIGNAL TRANSDUCTION;

EID: 84988527382     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cww022     Document Type: Review

References (56)

1. Amin MN, McLellan JS, Huang W, Orwenyo J, Burton DR, Koff WC, Kwong PD,Wang L-X. 2013. Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies. Nat Chem Biol. 9(8):521-526.
2. Becer CR, Gibson MI, Geng J, Ilyas R, Wallis R, Mitchell DA, Haddleton DM. 2010. High-affinity glycopolymer binding to human DC-SIGN and disruption of DC-SIGN interactions with HIV envelope glycoprotein. J Am Chem Soc. 132(43):15130-15132.
3. Bishop JR, Schuksz M, Esko JD. 2007. Heparan sulphate proteoglycans finetune mammalian physiology. Nature. 446(7139):1030-1037.
4. Bovin N, Tuzikov AB, Chinarev AA, Gambaryan AS. 2004. Multimeric glycotherapeutics: New paradigm. Glycoconj J. 21(8):471-478.
5. Courtney AH, Puffer EB, Pontrello JK, Yang ZQ, Kiessling LL. 2009. Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation. Proc Natl Acad Sci USA. 106(8):2500-2505.
6. Dam TK, Brewer CF. 2008. Effects of clustered epitopes in multivalent ligand-receptor interactions. Biochemistry. 47(33):8470-8476.
7. Dam TK, Gerken TA, Cavada BS, Nascimento KS, Moura TR, Brewer CF. 2007. Binding studies of alpha-GalNAc-specific lectins to the alpha-GalNAc (Tn-antigen) form of porcine submaxillary mucin and its smaller fragments. J Biol Chem. 282(38):28256-28263.
8. de Paz JL, Noti C, Bohm F,Werner S, Seeberger PH. 2007. Potentiation of fibroblast growth factor activity by synthetic heparin oligosaccharide glycodendrimers. Chem Biol. 14(8):879-887.
9. Duong BH, Tian H, Ota T, Completo G, Han S, Vela JL, Ota M, Kubitz M, Bovin N, Paulson JC, et al. 2010. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. J Exp Med. 207(1):173-187.
10. Evans SV, Mackenzie CR. 1999. Characterization of protein-glycolipid recognition at the membrane bilayer. J Mol Recognit. 12(3):155-168.
11. Galan MC, Dumy P, Renaudet O. 2013. Multivalent glyco(cyclo)peptides. Chem Soc Rev. 42(11):4599-4612.
12. Garcia-Vallejo JJ, Ambrosini M, Overbeek A, van Riel WE, Bloem K, Unger WWJ, Chiodo F, Bolscher JG, Nazmi K, Kalay H, et al. 2013. Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Mol Immunol. 53(4):387-397.
13. Gestwicki JE, Cairo CW, Strong LE, Oetien KA, Kiessling LL. 2002. Influencing receptor-ligand binding mechanisms with multivalent ligand architecture. J Am Chem Soc. 124(50):14922-14933.
14. Gorska K, Huang K-T, Chaloin C, Winssinger N. 2009. DNA-templated homoand heterodimerization of peptide nucleic acid encoded oligosaccharides that mimick the carbohydrate epitope of HIV. Angew Chem Int Ed. 48(41):7695-7700.
15. Hart GW, Copeland RJ. 2010. Glycomics hits the big time. Cell. 143(5): 672-676.
16. Horiya S, Bailey JK, Temme SJ, Guillen-Schlippe YV, Krauss IJ. 2014. Directed evolution of multivalent glycolpeptides tightly recognized by HIV antibody 2G12. J Am Chem Soc. 136(14):5407-5415.
17. Huang ML, Smith RAA, Trieger GW, Godula K. 2014. Glycocalyx remodeling with proteoglycan mimetics promotes neural specification in embryonic stem cells. J Am Chem Soc. 136(30):10565-10568.
18. Hudak JE, Canham SM, Bertozzi CR. 2013. Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoinvasion. Nat Chem Biol. 10(1):69-75.
19. Jayaraman N, Maiti K, Naresh K. 2013. Multivalent glycoliposomes and micelles to study carbohydrate-protein and carbohydrate-carbohydrate interactions. Chem Soc Rev. 42(11):4640-4656.
20. Kiessling LL, Grim JC. 2013. Glycopolymer probes of signal transduction. Chem Soc Rev. 42(10):4476-4491.
21. Kitov PI, Bundle DR. 2003. On the nature of the multivalency effect: A thermodynamic model. J Am Chem Soc. 125(52):16271-16284.
22. Kramer JR, Onoa B, Bustamante C, Bertozzi CR. 2015. Chemically tunable mucin chimeras assembled on living cells. Proc Natl Acad Sci USA. 112(41):12574-12579.
23. Lee D-W, Kim T, Park I-S, Huang Z, Lee M. 2012. Multivalent nanofibers of a controlled length: Regulation of bacterial cell agglutination. J Am Chem Soc. 134:14722-14725.
24. Lundquist JJ, Toone EJ. 2002. The cluster glycoside effect. Chem Rev. 102(2):555-578.
25. Mager MD, LaPointe V, Stevens MM. 2011. Exploring and exploiting chemistry at the cell surface. Nat Chem. 3(8):582-589.
26. Macauley MS, Pfrengle F, Rademacher C, Nycholat CM, Gale AJ, von Drygalski A, Paulson JC. 2013. Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis. J Clin Invest. 123:3074-3083.
27. Mammen M, Choi S-K, Whitesides GM. 1998. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed. 37(20):2754-2794.
28. Marra A, Moni L, Pazzi D, Corallini A, Bridi D, Dondoni A. 2008. Synthesis of sialoclusters appended to calix[4]arene platforms via multiple azide-alkyne cycloaddition. New inhibitors of hemaglutinnation and cytopathic effect mediated by BK and influenza Aviruses. Org Biomol Chem. 6(8):1396-1409.
29. Marradi M, Chiodo F, García I, Penadés S. 2013. Glyconanoparticles as multifunctional and multimodal carbohydrate systems. Chem Soc Rev. 42(11): 4728-4745.
30. Martinez A, Mellet CO, Fernandez JMG. 2013. Cyclodextrin-based multivalent glycodisplays: Covalent and supramolecular conjugates to assess carbohydrate-protein interactions. Chem Soc Rev. 42(11):4746-4773.
31. Mauris J, M.antelli F, Woodward AM, Cao Z, Bertozzi CR, Panjwani N, Godula K, Argueso P. 2013.Modulation of ocular surface glycocalyx barrier function by a galectin-3 N-terminal deletion mutant and membrane-anchored synthetic glycopolymers. PLoS ONE. 8(8):e72304.
32. Miura Y, Hoshino Y, Seto H. 2016. Glycopolymer nanobiotechnology. Chem Rev. 116(4):1673-1692.
33. Nelson A, Belitsky JM, Vidal S, Joiner CS, Baum LG, Stoddart JF. 2004. A selfassmebled multivalent pseudopolyrotaxane for binding galectin-1. J Am Chem Soc. 126(38):11914-11922.
34. Oyelaran O, Li Q, Farnsworth D, Gildersleeve JC. 2009. Micorarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies. J Proteome Res. 8(7):3529-3538.
35. Paszek MJ, DuFort CC, Rossier O, Bainer R, Mouw JK, Godula K, Hudak JE, Lakins JN, Wijekoon AC, Cassereau L, et al. 2014. The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature. 511(7509):319-325.
36. Polizzotti BD, Kiick KL. 2006. Effects of polymer structure on the inhibition of the cholera toxin by linear poplypeptide-based glycopolymers. Biomacromolecules. 7(2):483-490.
37. Pulsipher A, Griffin ME, Stone SE, Brown JM, Hsieh-Wilson LC. 2014. Directing neuronal signaling through cell-surface glycan engineering. J Am Chem Soc. 136(10):6794-6797.
38. Pulsipher A, Griffin ME, Stone SE, Hsieh-Wilson LC. 2015. Long-lived engineering of glycans to direct stem cell fate. Angew Chem Int Ed Engl. 54(5):1466-1470.
39. Rabuka D, Forstner MB, Groves JT, Berttozi CR. 2008. Noncovalent cell surface engineering: Incorporation of bioactive synthetic glycopolymers into cellular membranes. J Am Chem Soc. 130(18):5947-5953.
40. Rademacher TW, Parekh RB, Dwek RA. 1988. Glycobiology. Annu Rev Biochem. 57:785-838.
41. Rawat M, Gama CI, Matson JB, Hsieh-Wilson LC. 2008. Neuroactive chondroitin sulfate glycomimetics. J Am Chem Soc. 130(10):2959-2961.
42. Razi N, Varki A. 1998. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sci USA. 95:7469-74.
43. Restuccia A, FettisMM, Hudalla GA. 2015. Glycomaterials for immunomodulation, immunotherapy, and infection prophylaxis. doi: 10.1039/c5tb01780g.
44. Restuccia A, Tian YF, Collier JH, Huddala GA. 2015. Self-assembled glycopeptide nanofibers as modulators of galectin-1 bioactivity. Cell Mol Bioeng. 8(3):471-487.
45. Ruff Y, Lehn J-M. 2008. Glycodynamers: Fluorescent dynamic analogues of polysaccharides. Angew Chem Int Ed Engl. 47(19):3556-3559.
46. Ryu J-H, Lee E, Lim Y, Lee M. 2007. Carbohydrate-coated supramolecular structures: Tranformation of nanofibers into spherical micelles triggered by guest encapsulation. J Am Chem Soc. 129:4808-4814.
47. Sansone F, Casnati A. 2013. Multivalent glycocalixarenes for recognition of biological macromolecules: Glycocalyx mimics capable of multitasking. Chem Soc Rev. 42(11):4623-4639.
48. Sheng GJ, Oh YI, Chang SK, Hsieh-Wilson LC. 2013. Tunable heparan sulfate mimetics for modulating chemokine activity. J Am Chem Soc. 135(30): 10898-10901.
49. Sinha S, Surolia A. 2005. Oligomerization endows enormous stability to soybean agglutinin: A comparison of the stability of the monomer and tetramer of soybean agglutinin. Biophys J. 88(6):4243-4251.
50. Steiner K, Hanreich A, Kainz B, Hitchen PG, Dell A, Messner P, Schaffer C. 2008. Recombinant glycans on an S-layer self-assembly protein: A new dimension for nanopatterned biomaterials. Small. 4(10):1728-1740.
51. Talaga ML, Fan N, Fueri AL, Brown RK, Chabre YM, Bandyopadhyay P, Roy R, Dam TK. 2014. Significant other half of a glycoconjugate: Contributions of scaffolds to lectin-glycoconjugate interactions. Biochemistry. 53(27):4445-4454.
52. Temme JS, MacPherson IS, DeCourcey JF, Krauss IJ. 2014. High temperature SELMA: Evolution of DNA-supported oligomannose clusters which are tightly recognized by HIV bnAb 2G12. J Am Chem Soc. 136(5): 1726-1729.
53. Unger WWJ, van Kooyk Y. 2011. Dressed for success C-type lectin receptors for the delivery of glycol-vaccines to dendritic cells. Curr Opin Immunol. 23(1):131-137.
54. Varki A, Lowe JB. 2009. Biological roles of glycans. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Essentials of Glycobiology. 2nd ed., Chapter 6. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press.
55. Venkataraman G, Raman R, Sasisekharan V, Sasisekharan R. 1999. Molecular characteristics of fibroblastgrowth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex. Proc Natl Acad Sci USA. 96(7):3658-3663.
56. Vico RV, Voskuhl J, Ravoo BJ. 2011. Multivalent interaction of cyclodextrin vesicles, carbohydrate guests, and lectins: A kinetic investigation. Langmuir. 27(4):1391-1397.